PO.TB10.06 · 肿瘤生物学
数字空间分析揭示肝细胞癌肿瘤与基质区室间的免疫异质性
Digital spatial profiling reveals immune heterogeneity across tumor and stromal compartments in hepatocellular carcinoma
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:肝细胞癌(HCC)是全球最具破坏性的恶性肿瘤之一,尤其在东亚地区。尽管过去十年免疫检查点抑制剂取得了重大进展,许多患者仍反应不佳,凸显了更好地理解肿瘤异质性(尤其是在空间层面)的必要性。GeoMx™ 数字空间分析仪(DSP)是一种空间生物学平台,能够对 FFPE 样本进行高复数、原位分析,从而在保留空间背景的同时对不同组织区室内进行分子表征。在本研究中,DSP 被用于利用 HCC 患者的 FFPE 样本进行免疫分析。
方法:共使用了 4 个免疫相关板块进行 DSP 蛋白质分析。使用了 30 张 HCC FFPE 切片,从肿瘤和肿瘤基质组织中识别出 341 个感兴趣区域进行 DSP 分析。选择了四种形态标志物(CD45/Vimentin/CK8/18/SYTO83)进行免疫荧光(IF)染色,以指导针对组织结构和不同细胞类型的感兴趣区域(ROI)选择。
结果:DSP 分析揭示了 HCC 组织内不同的免疫模式。免疫相关标志物的主成分分析将样本区域按肿瘤和基质明确分层,凸显了免疫参与的空间异质性。值得注意的是,与肿瘤区域相比,基质区室表现出更强的免疫活化标志物(如 CD45)差异表达,尤其是 T 细胞相关蛋白如 CD3、CD4 和 CD8。定量分析表明,无论组织区室如何,通过 IF 和 DSP 测量的 CD45 表达都存在强相关性。IF 染色证实大多数 HCC 样本的肿瘤区域内 CD45 表达较低(<2%),表明免疫细胞浸润有限。然而,一部分样本仍在基质、肿瘤或两个区室中表现出相对较高的 CD45 表达,提示不同患者间存在可变的免疫参与。总体而言,这些结果说明了 HCC 中免疫浸润的多样化模式。
结论:本研究凸显了 HCC 肿瘤微环境内免疫细胞浸润的空间异质性。按组织来源对样本进行分层以及基质区域中免疫活化标志物的独特表达,强调了区室特异性分析的重要性。DSP 与 IF 定量在 CD45 表达上的高度一致性支持了空间分析方法的稳健性。这些发现可能为空间引导的免疫治疗策略的开发提供信息。
查看英文原文 English abstract
Introduction : Hepatocellular Carcinoma (HCC) is one of the most devastating malignancies around the world, especially in East Asia. Despite significant advances in immune checkpoint inhibitors in the past decade, many patients show poor response, highlighting the need to better understand tumor heterogeneity, especially at the spatial level. GeoMx™ Digital Spatial Profiler (DSP) is a spatial biology platform that enables high-plex, in situ profiling of FFPE samples, allowing molecular characterization within distinct tissue compartments while preserving spatial context. In this study, DSP was exploited for immune profiling utilizing FFPE samples from HCC patients.
Methods: A total of 4 immune-related panels were used for DSP protein profiling. Thirty HCC FFPE slides were used, and 341 regions of interest were identified from tumor and tumor stroma tissue for DSP analysis. Four morphology markers (CD45/Vimentin/CK8/18/SYTO83) were selected for Immunofluorescence (IF) staining to guide the regions of interest (ROI) selection for tissue structure and distinct cell types.
Results: DSP analysis revealed distinct immune patterns within HCC tissues. Principal component analysis of immune-related markers stratified regions of samples distinctly by tumor and stroma, highlighting the spatial heterogeneity of immune engagement. Notably, stromal compartments exhibited stronger differential expression of immune activation markers (e.g, CD45), particularly T cell-associated proteins such as CD3, CD4, and CD8 compared to tumor regions. Quantitative analysis demonstrated a strong correlation of CD45 expression measured by IF and DSP regardless of tissue compartments. IF staining confirmed low CD45 expression (<2%) within tumor regions in majority of HCC samples, indicating limited immune cell infiltration. However, a subset of samples still showed relatively higher CD45 expression in either the stroma, tumor, or both compartments, suggesting variable immune engagement across patients. Collectively, these results illustrate diverse patterns of immune infiltration in HCC.
Conclusions: This study highlights the spatial heterogeneity of immune cell infiltration within the tumor microenvironment of HCC. Stratification of samples by tissue origin and the distinct expression of immune activation markers in stromal regions underscore the importance of compartment-specific analysis. The strong concordance between DSP and IF quantification for CD45 expressions supports the robustness of spatial profiling approaches. These findings may inform the development of spatially guided immunotherapeutic strategies.
利益披露 Disclosure
M. Qing,
Johnson & Johnson Employment, Stock.
Q. Wu,
Johnson & Johnson Employment.
X. Lyu,
Johnson & Johnson Employment, Stock.
T. Chen,
Johnson & Johnson Employment.
M. Xia,
Johnson & Johnson Employment, Stock.
J. J. Rusbuldt,
Johnson & Johnson Employment.
D. Smirnov,
Johnson & Johnson Employment, Stock.
F. Berisha,
Johnson & Johnson Employment, Stock.
L. Zhou,
Johnson & Johnson Employment, Stock.
C. Yen, None.